000028063 000__ 01864cam\a22003375i\4500
000028063 000__ 01919nam\a2200361Ia\4500
000028063 001__ 28063
000028063 003__ SzGeWIPO
000028063 005__ 20230120174703.0
000028063 008__ 171027s2017\\\\nyr\\\\\rb\\\\000\|\eng\d|\eng\d
000028063 035__ $$a(OCoLC)1160937499
000028063 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000028063 1102_ $$aWorld Intellectual Property Organization
000028063 24510 $$aVaccines: Accelerating Innovation and Access :$$bGlobal Challenges Report.
000028063 264_1 $$a[Geneva, Switzerland] :$$b[World Intellectual Property Organization],$$c2017.
000028063 300__ $$a[English] ;$$c[28] cm.
000028063 336__ $$atext$$btxt$$2rdacontent
000028063 337__ $$aunmediated$$bn$$2rdamedia
000028063 338__ $$avolume$$bnc$$2rdacarrier
000028063 4901_ $$aWIPO Publication
000028063 520__ $$aThis Global Challenges Report describes the innovation process for vaccines. It explains how the restricted availability of vaccines is due to impediments at every stage of the process. Most of these obstacles are manageable, and intellectual property (IP) rights are associated with only some of them. The analysis aims to put into perspective debates around health innovation and the availability of health technologies in developing countries, especially with respect to the role of IP. In particular, it provides an overview of how IP has been used to meet global health challenges in the vaccines field, and considers whether lessons can be drawn to inform other important health technologies.
000028063 542__ $$fLicense: CC BY 3.0 IGO
000028063 650_0 $$aIntellectual property$$zDeveloping countries.
000028063 650_4 $$aVaccines
000028063 650_4 $$aGlobal Health
000028063 651_0 $$aDeveloping countries$$xCommerce$$xLaw and legislation.
000028063 7001_ $$aDebacker, Koenraad.
000028063 830_0 $$aWIPO Publication.
000028063 8564_ $$uhttp://www.wipo.int/edocs/pubdocs/en/wipo_pub_gc_16.pdf$$yView electronic version
000028063 903__ $$aWIPO Publication
000028063 942__ $$cMON$$2ddc
000028063 980__ $$aBIB
000028063 999__ $$c31119$$d31119